150 related articles for article (PubMed ID: 38376505)
1. Section E6.7-6.12 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in solid tumors.
Church AJ; Akkari Y; Deeb K; Kolhe R; Lin F; Spiteri E; Wolff DJ; Shao L;
Genet Med; 2024 Apr; 26(4):101070. PubMed ID: 38376505
[TBL] [Abstract][Full Text] [Related]
2. Section E6.1-6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes.
Akkari Y; Baughn LB; Kim A; Karaca E; Raca G; Shao L; Mikhail FM;
Genet Med; 2024 Apr; 26(4):101054. PubMed ID: 38349293
[TBL] [Abstract][Full Text] [Related]
3. Section E6.5-6.8 of the ACMG technical standards and guidelines: chromosome studies of lymph node and solid tumor-acquired chromosomal abnormalities.
Cooley LD; Morton CC; Sanger WG; Saxe DF; Mikhail FM
Genet Med; 2016 Jun; 18(6):643-8. PubMed ID: 27124786
[TBL] [Abstract][Full Text] [Related]
4. Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities.
Mikhail FM; Heerema NA; Rao KW; Burnside RD; Cherry AM; Cooley LD
Genet Med; 2016 Jun; 18(6):635-42. PubMed ID: 27124785
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Shao L; Akkari Y; Cooley LD; Miller DT; Seifert BA; Wolff DJ; Mikhail FM;
Genet Med; 2021 Oct; 23(10):1818-1829. PubMed ID: 34131312
[TBL] [Abstract][Full Text] [Related]
6. Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization.
Mascarello JT; Hirsch B; Kearney HM; Ketterling RP; Olson SB; Quigley DI; Rao KW; Tepperberg JH; Tsuchiya KD; Wiktor AE;
Genet Med; 2011 Jul; 13(7):667-75. PubMed ID: 21738013
[TBL] [Abstract][Full Text] [Related]
7. Section E6.5 of the ACMG technical standards and guidelines: chromosome studies for solid tumor abnormalities.
Cooley LD; Mascarello JT; Hirsch B; Jacky PB; Rao PN; Saxe D; Rao KW;
Genet Med; 2009 Dec; 11(12):890-7. PubMed ID: 20010366
[TBL] [Abstract][Full Text] [Related]
8. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC).
Mikhail FM; Biegel JA; Cooley LD; Dubuc AM; Hirsch B; Horner VL; Newman S; Shao L; Wolff DJ; Raca G
Genet Med; 2019 Sep; 21(9):1903-1916. PubMed ID: 31138931
[TBL] [Abstract][Full Text] [Related]
9. American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders.
Cooley LD; Lebo M; Li MM; Slovak ML; Wolff DJ;
Genet Med; 2013 Jun; 15(6):484-94. PubMed ID: 23619274
[TBL] [Abstract][Full Text] [Related]
10. Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee.
Larson DP; Akkari YM; Van Dyke DL; Raca G; Gardner JA; Rehder CW; Kaiser-Rogers KA; Eagle P; Yuhas JA; Gu J; Toydemir RM; Kearney H; Conlin LK; Tang G; Dolan MM; Ketterling RP; Peterson JF
Arch Pathol Lab Med; 2021 Feb; 145(2):176-190. PubMed ID: 32886736
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Rehder C; Bean LJH; Bick D; Chao E; Chung W; Das S; O'Daniel J; Rehm H; Shashi V; Vincent LM;
Genet Med; 2021 Aug; 23(8):1399-1415. PubMed ID: 33927380
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Zhang S; Taylor AK; Huang X; Luo B; Spector EB; Fang P; Richards CS;
Genet Med; 2018 Dec; 20(12):1489-1498. PubMed ID: 30297698
[TBL] [Abstract][Full Text] [Related]
13. Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Spector E; Behlmann A; Kronquist K; Rose NC; Lyon E; Reddi HV;
Genet Med; 2021 May; 23(5):799-812. PubMed ID: 33795824
[TBL] [Abstract][Full Text] [Related]
14. Section E6 of the ACMG technical standards and guidelines: chromosome studies for acquired abnormalities.
Hirsh B; Brothman AR; Jacky PB; Rao KW; Wolff DJ
Genet Med; 2005 Sep; 7(7):509-13. PubMed ID: 16170243
[No Abstract] [Full Text] [Related]
15. A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays.
Li MM; Monzon FA; Biegel JA; Jobanputra V; Laffin JJ; Levy B; Leon A; Miron P; Rossi MR; Toruner G; Alvarez K; Doho G; Dougherty MJ; Hu X; Kash S; Streck D; Znoyko I; Hagenkord JM; Wolff DJ
Cancer Genet; 2015 Nov; 208(11):525-36. PubMed ID: 26454669
[TBL] [Abstract][Full Text] [Related]
16. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013.
South ST; Lee C; Lamb AN; Higgins AW; Kearney HM;
Genet Med; 2013 Nov; 15(11):901-9. PubMed ID: 24071793
[TBL] [Abstract][Full Text] [Related]
17. Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms.
Sahajpal NS; Mondal AK; Tvrdik T; Hauenstein J; Shi H; Deeb KK; Saxe D; Hastie AR; Chaubey A; Savage NM; Kota V; Kolhe R
J Mol Diagn; 2022 Dec; 24(12):1279-1291. PubMed ID: 36265723
[TBL] [Abstract][Full Text] [Related]
18. [Impact of tumorcytogenetics in tumor diagnostics].
Wenzel F; Röthlisberger B
Ther Umsch; 2008 Sep; 65(9):473-80. PubMed ID: 18791960
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization: molecular probes for diagnosis of pediatric neoplastic diseases.
Raimondi SC
Cancer Invest; 2000; 18(2):135-47. PubMed ID: 10705876
[TBL] [Abstract][Full Text] [Related]
20. Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Waggoner D; Wain KE; Dubuc AM; Conlin L; Hickey SE; Lamb AN; Martin CL; Morton CC; Rasmussen K; Schuette JL; Schwartz S; Miller DT;
Genet Med; 2018 Oct; 20(10):1105-1113. PubMed ID: 29915380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
